On the one hand, a univariate survival analysis showed that tumor size (P=0.031), lymph node metastasis (P < 0.001), clinicopathological stage (P < 0.001), and mutant P53 expression (P=0.038) were associated with overall survival. This evidence concerns the gene TP53 and neoplasm.